Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncostatin M, a multifunctional cytokine.

M Tanaka1, A Miyajima

  • 1Institute of Molecular and Cellular Biosciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, 113-0032 Tokyo, Japan. tanaka@iam.u-tokyo.ac.jp

Reviews of Physiology, Biochemistry and Pharmacology
|June 18, 2003
PubMed
Summary

Oncostatin M (OSM), an IL-6 subfamily cytokine, impacts tumor cell proliferation, inflammation, and development. This review covers OSM

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laparoendoscopic Single-site Plus 1-port Donor Nephrectomy: Division of Roles to Shorten Warm Ischemic Time.

Transplantation proceedings·2018
Same author

Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms.

The pharmacogenomics journal·2016
Same author

Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma.

British journal of cancer·2013
Same author

The prognostic significance of vasohibin-1 expression in patients with prostate cancer.

British journal of cancer·2013
Same author

Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer.

British journal of cancer·2012
Same author

Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma.

British journal of cancer·2011

Area of Science:

  • Biochemistry and Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Oncostatin M (OSM) is a cytokine within the Interleukin (IL)-6 subfamily.
  • OSM shares structural and functional similarities with leukemia inhibitory factor (LIF).
  • OSM interacts with both LIF receptor and its own specific receptor.

Purpose of the Study:

  • To review the diverse biological activities of Oncostatin M.
  • To elucidate the receptor usage and signal transduction pathways of OSM.
  • To highlight OSM's roles beyond its initial identification in tumor cell inhibition.

Main Methods:

  • Literature review of existing studies on OSM.
  • Analysis of OSM's molecular interactions and signaling pathways.
  • Synthesis of data on OSM's functions in various biological contexts.

Main Results:

  • OSM exhibits multifaceted roles in inflammation, hematopoiesis, and developmental processes.
  • OSM's biological functions are mediated through specific receptor complexes.
  • Evidence suggests broader implications of OSM in cellular regulation.

Conclusions:

  • OSM is a key regulator with significant roles in multiple physiological and pathological processes.
  • Understanding OSM's signaling is crucial for therapeutic targeting.
  • Further research into OSM's activities will uncover new biological insights.

Related Experiment Videos